The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. Tumor microenvironments, however, are difficult to study in vitro. Cells cultured as monolayers exhibit less resistance to therapy than those grown in vivo and an alternative research model more representative of the in vivo tumor is more desirable. SS1P is an immunotoxin composed of the Fv portion of a mesothelin-specific antibody fused to a bacterial toxin that is presently undergoing clinical trials in mesothelioma. METHODOLOGY/PRINCIPAL FINDINGS: Here, we examined how the tumor microenvironment affects the penetration and killing activity of SS1P in a new three-dimensional (3D) spheroid model cultured in vitro using the human mesothelioma cell line (NCI-H226) and two primary cell lines isolated from the ascites of malignant mesothelioma patients. Mesothelioma cells grown as monolayers or as spheroids expressed comparable levels of mesothelin; however, spheroids were at least 100 times less affected by SS1P. To understand this disparity in cytotoxicity, we made fluorescence-labeled SS1P molecules and used confocal microscopy to examine the time course of SS1P penetration within spheroids. The penetration was limited after 4 hours. Interestingly, we found a significant increase in the number of tight junctions in the core area of spheroids by electron microscopy. Expression of E-Cadherin, a protein involved in the assembly and sealing of tight junctions and highly expressed in malignant mesothelioma, was found significantly increased in spheroids as compared to monolayers. Moreover, we found that siRNA silencing and antibody inhibition targeting E-Cadherin could enhance SS1P immunotoxin therapy in vitro. CONCLUSION/SIGNIFICANCE: This work is one of the first to investigate immunotoxins in 3D tumor spheroids in vitro. This initial description of an in vitro tumor model may offer a simple and more representative model of in vivo tumors and will allow for further investigations of the microenvironmental effects on drug penetration and tumor cell killing. We believe that the methods developed here may apply to the studies of other tumor-targeting antibodies and immunoconjugates in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These features confer to spheroids a similar anticancer drug resistance profile [124,125] to that exhibited by real solid tumors.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817 · cited 1×
“In vitro multicellular cancer spheroids, therefore, have begun to bridge the complexity gap between monolayer cell culture and in vivo tumors and have become valuable models in the study of drug resistance [6].”
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Nevertheless, spheroids offer an advantage based on the ability to examine the distribution of drugs in the absence of complicating factors such as pharmacokinetics, which often differ between mice and humans [33].”
BackgroundJohnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856 · cited 1×
“resistance acquired by tumor cells may contribute to difficulties in translating promising findings from in vitro studies into therapy [5].”
BackgroundTransport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691 · cited 1×
“ies and immunoconjugates within tumor masses [1].”
Multicellular resistance: a paradigm for clinical resistance?
Desoize, B. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00086-x · Cited by 400 · cited 1×
“and may be explained by “multicellular resistance,” a mechanism for drug resistance attributed to cell-cell contacts, cell-matrix contacts, and the three-dimensional (3D) shape found in tissue”
BackgroundMesothelin targeted cancer immunotherapy
Hassan, R., & Ho, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.028 · Cited by 340 · cited 6×
“Although the biological function of mesothelin remains unclear, mesothelin’s limited expression in normal tissue and high expression in various cancers make it an attractive candidate for immunotherapy [12].”
BackgroundInfluentialSelf-citationPark, C. C., Zhang, H., Pallavicini, M., Gray, J. W., Baehner, F., Park, C. J., & Bissell, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3071 · Cited by 326 · cited 1×
“. In fact, inhibition of integrins has been shown to enhance breast cancer therapy”
BackgroundDynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305 · cited 1×
“. Interestingly, we found that the inhibitory antibody sensitizes the spheroids to immunotoxin therapy if the antibody was added before the formation of spheroids but not after. In the present study, we showed how silencing E-Cadherin expression or blocking its adhesive function does not completely disrupt spheroids,…”
Resultβ1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220
Asbestos-associated chromosomal changes in human mesothelial cells.
Lechner, J. F., Tokiwa, T., LaVeck, M., Benedict, W. F., Banks-Schlegel, S., Yeager, H., Banerjee, A., & Harris, C. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3884 · Cited by 212 · cited 1×
“Mesothelioma is a fatal cancer of the mesothelium and predominantly forms from previous exposure to asbestos [7].”
BackgroundA Binding Domain on Mesothelin for CA125/MUC16
Kaneko, O., Gong, L., Zhang, J., Hansen, J. K., Hassan, R., Lee, B., & Ho, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806776200 · Cited by 204 · cited 2×
“The mucin CA125/MUC16 is also highly expressed at the cell surface in mesothelioma and ovarian cancer [15].”
BackgroundSelf-citationYaziji, H., Battifora, H., Barry, T. S., Hwang, H. C., Bacchi, C. E., McIntosh, M. W., Kussick, S. J., & Gown, A. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800534 · Cited by 191 · cited 1×
“The expression of these markers in spheroids was in general consistent with those of previously published mesothelioma specimens [17,18].”
ResultMesothelin Expression in Human Lung Cancer
Ho, M., Bera, T. K., Willingham, M. C., Onda, M., Hassan, R., FitzGerald, D., & Pastan, I. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2161 · Cited by 156 · cited 5×
“Electron microscopy preparation A spheroid cell pellet was fixed in 4% formaldehyde/2% glutaraldehyde (Tousimis, Rockville, MD) in 0.1M cacodylate buffer (pH 7.4), then post-fixed in 1% osmium tetroxide (Electron Microscopy Sciences, Ft. Washington, PA) in the same buffer.”
BackgroundMethodInfluentialSelf-citationBarbone, D., Yang, T.-M., Morgan, J. R., Gaudino, G., & Broaddus, V. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709698200 · Cited by 150 · cited 2×
“Louis, MO) was coated with 50 mL of 5 mg/mL of poly-HEMA (poly-2hydroxyethyl methacrylate; Sigma-Aldrich) in 95% ethanol and evaporated with lid on at room temperature for 72 hours [11].”
BackgroundMethodSelf-citationCreaney, J., Yeoman, D., Demelker, Y., Segal, A., Musk, A. W., Skates, S. J., & Robinson, B. W. S. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318180477b · Cited by 121 · cited 1×
“Mesothelin is highly expressed in mesothelioma, as well as ovarian cancer and lung cancer [12,13], and has been shown to be a biomarker for the diagnosis of mesothelioma [14].”
BackgroundGreen, S. K., Francia, G., Isidoro, C., & Kerbel, R. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.149.3.2 · Cited by 107 · cited 1×
“In the second approach, we used a mAb (SHE78-7) targeting E-Cadherin to block the adhesive function of E-Cadherin [28].”
MethodPseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of Mcl-1
Du, X., Youle, R. J., FitzGerald, D. J., & Pastan, I. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00813-09 · Cited by 107 · cited 1×
“. A recent study illustrated that the overexpression of Mcl-1 and Bcl-xL inhibited PE immunotoxin-induced cancer cell death”
BackgroundSelf-citationApplication of immunohistochemistry to the diagnosis of malignant mesothelioma.
Marchevsky, A. M. (2008) · PubMed · doi:10.5858/2008-132-397-aoittd · Cited by 107
Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax
Narasimhan, S. R., Yang, L., Gerwin, B. I., & Broaddus, V. C. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.1.l165 · Cited by 91 · cited 1×
“Malignant mesothelioma (MM) is often resistant to chemotherapy [8] and radiation [9].”
BackgroundSelf-citationE-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless
Simsir, A., Fetsch, P. A., Mehta, D., Zakowski, M. F., & Abati, A. D. (1999) · Diagnostic Cytopathology · doi:10.1002/(sici)1097-0339(199903)20:3<125::aid-dc3>3.0.co;2-v · Cited by 89 · cited 1×
“We believe this method has additional applications for identifying novel molecular targets in tumors. We show in this work that E-Cadherin is highly expressed in 3D mesothelioma but not in monolayers. Interestingly, E-Cadherin is among one of the most important biomarkers that have been proposed as useful in the diagn…”
MethodZhang, Y., Xiang, L., Hassan, R., & Pastan, I. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708101104 · Cited by 83
Self-citationKitazume, H., Kitamura, K., Mukai, K., Inayama, Y., Kawano, N., Nakamura, N., Sano, J., Mitsui, K., Yoshida, S., & Nakatani, Y. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000225)90:1<55::aid-cncr8>3.0.co;2-p · Cited by 80 · cited 1×
“Interestingly, E-Cadherin is among one of the most important biomarkers that have been proposed as useful in the diagnosis of MM [34,35].”
BackgroundUltrastructural features of diffuse malignant mesotheliomas
Oury, T. D., Hammar, S. P., & Roggli, V. L. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90006-5 · Cited by 79 · cited 1×
“presence of long and branching microvilli on cell surfaces, a feature characteristic of well-differentiated MM in vivo [19].”
BackgroundBcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids
Yang, T.-M., Barbone, D., Fennell, D. A., & Broaddus, V. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0320oc · Cited by 76 · cited 2×
“A previous study also revealed that high expression of Mcl-1 in 3D lung cancer spheroids caused its drug resistance [22].”
ResultSelf-citationSynergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing Mice
Zhang, Y., Xiang, L., Hassan, R., Paik, C. H., Carrasquillo, J. A., Jang, B., Le, N., Ho, M., & Pastan, I. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0346 · Cited by 75 · cited 1×
“mouse models showing marked synergy between SS1P and chemotherapy”
BackgroundSelf-citationHigh Shed Antigen Levels within Tumors: An Additional Barrier to Immunoconjugate Therapy
Zhang, Y., & Pastan, I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0324 · Cited by 67
Hassan, R., Broaddus, V. C., Wilson, S. M., Liewehr, D. J., & Zhang, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1592 · Cited by 67
Self-citationDecker, T. W., Oelsner, M., Kreitman, R. J., Salvatore, G., Wang, Q.-C., Pastan, I. H., Peschel, C., & Licht, T. (2003) · Blood · doi:10.1182/blood-2003-04-1317 · Cited by 62 · cited 1×
“Previous studies on B cells of chronic lymphocytic leukemia showed that the mitochondria-dependent Bcl-2 signaling pathway of apoptosis plays a critical role in the killing of targeted cancer cells by immunotoxins”
BackgroundPrognostic factors in mesothelioma
Steele, J. P. C., Klampatsa, A., Fennell, D. A., Pallaska, A., Sheaff, M. T., Evans, M. T., Shamash, J., & Rudd, R. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.009 · Cited by 62
Asbestos-Associated Chromosomal Changes in Human Mesothelial Cells
Lechner, J. F., Tokiwa, T., Yeager, H., & Harris, C. C. (1985) · Springer eBooks · doi:10.1007/978-3-642-70630-1_24 · Cited by 42
Zhang, Y., Hansen, J. K., Xiang, L., Kawa, S., Onda, M., Ho, M., Hassan, R., & Pastan, I. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2405 · Cited by 42 · cited 1×
“Due to the fact that immunotoxins have a relatively short life in circulation (20 minutes in mice and 2– 8 hours in humans) [27], the time that a tumor is exposed to high immunotoxin concentrations is relatively short.”
BackgroundSelf-citationE-Cadherin and tight junctions between epithelial cells of different animal species
Lázaro, A., Monroy, A., Contreras, R. G., Fiorentino, R., Roldán, M. L., Cereijido, M., Shoshani, L., & Flores-Maldonado, C. (2002) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0827-8 · Cited by 37 · cited 1×
“, we examined the expression of a panel of cell contact proteins. Expression of E-Cadherin, a protein involved with tight junctions, was significantly increased in spheroids. ZO-1, another tight junction protein, was also modestly increased in spheroids. However, Connexin-32, the protein responsible for the formation…”
BackgroundMalignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates
Daubriac, J., Fleury‐Feith, J., Kheuang, L., Galipon, J., Saint-Albin, A., Renier, A., Giovannini, M., Galateau-Sallé, F., & Jaurand, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.32 · Cited by 36 · cited 1×
“Spheroids have been observed in the pleural fluid of human MM and linked to increased malignancy [16].”
BackgroundWang, Y., Zhao, R., Chattopadhyay, S., & Goldman, I. D. (2002) · PubMed · Cited by 29
Prognostic Factors in Mesothelioma
Steele, J. P. C., & Fennell, D. A. (2006) · Springer eBooks · doi:10.1007/0-387-28274-2_27 · Cited by 11
Cited by
Spherical Cancer Models in Tumor Biology
Weiswald, L.-B., Bellet, D., & Dangles-Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,141
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024
“Since then, several methods have been used to generate tumor spheroids: spontaneous aggregation [19,20], spinner flasks [21], rotary cell culture systems [3,22], poly-2-hydroxyethyl methacrylate (polyHema)-coated plates [23,24], hanging drops [25], liquid overlay on agar [26-28], low binding plates [29,30], gel/ matri…”
MethodThree-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440
Xenaki, K. T., Oliveira, S., & van Bergen en Henegouwen, P. M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01287 · Cited by 289
“Inhibition of the adherens junction protein E-cadherin (and therefore disruption of cell–cell junctions) resulted in improved penetration and cytotoxicity of an immu-notoxin used in a 3D cell culture system of tumor cells (28).”
Three-dimensional in vitro culture models in oncology research
Jubelin, C., Muñoz-Garcia, J., Griscom, L., Cochonneau, D., Ollivier, E., Heymann, M.-F., Vallette, F. M., Oliver, L., & Heymann, D. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00887-3 · Cited by 264
Metadata
- Authors
- Xiang, X., Phung, Y., Feng, M., Nagashima, K., Zhang, J., Broaddus, V. C., Hassan, R., FitzGerald, D., & Ho, M.
- Affiliations
- National Institutes of Health (US)
- University of California, San Francisco (US)
- Corresponding author
- Ho, Mitchell
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-31
- Volume
- 6
- Issue
- 1
- Pages
- e14640
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3031536
- OpenAlex
- W1994540190
- Cited by
- 51
- References
- 37
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 3 · 2022: 4 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 5
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, public-domain)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Health and Human Services (HHSN26120080001E)
- Mesothelioma Applied Research Foundation
- National Institutes of Health (HHSN26120080001E)
- National Cancer Institute (HHSN26120080001E)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Toxin Mechanisms and Immunotoxins
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- malignant mesothelioma, mesothelin, tumor microenvironment, tumor spheroids, drug penetration, tight junctions, E-cadherin, immunoconjugates, siRNA knockdown
- MeSH terms
- Antibodies, Antibodies, Monoclonal, Immunotoxins, Humans, Kinetics, Mesothelioma, Microscopy, Electron, Tumor Cells, Cultured, Cadherins, Spheroids, Cellular, Cell Culture Techniques, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.